Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: Evaluation by flow cytometric analysis of intracellular WAS protein expression

Blood

Volumn 100, Issue 4, 2002, Pages 1208-1214

  Yamaguchi, Koji ^{a,b,c,d,e,f,g,h}   Ariga, Tadashi ^{a,b,c,d,e,f,g,h}   Yamada, Masafumi ^{a,b,c,d,e,f,g,h}   Nelson, David L ^{a,b,c,d,e,f,g,h}   Kobayashi, Ryouji ^{a,b,c,d,e,f,g,h}   Kobayashi, Chie ^{a,b,c,d,e,f,g,h}   Noguchi, Yasushi ^{a,b,c,d,e,f,g,h}   Ito, Yasuhiko ^{a,b,c,d,e,f,g,h}   Katamura, Kenji ^{a,b,c,d,e,f,g,h}   Nagatoshi, Yoshihisa ^{a,b,c,d,e,f,g,h}   Kondo, Satoshi ^{a,b,c,d,e,f,g,h}   Katoh, Hiroyuki ^{a,b,c,d,e,f,g,h}   Sakiyama, Yukio ^{a,b,c,d,e,f,g,h}  

^a Department of Surgical Oncology   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Ibaraki Children's Hospital   (Japan)

^e CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN WAS; UNCLASSIFIED DRUG;

ARTICLE; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; GENE DELETION; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; INFANT; MEMORY CELL; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WISKOTT ALDRICH SYNDROME; X CHROMOSOME;

EID: 0037103355     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0211     Document Type: Article

References (25)

1. Familiärer, angeborener morbus werlhofii
2. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea
3. A multiinstitutional survey of the Wiskott-Aldrich syndrome
4. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
5. WASP levels in platelets and lymphocytes of Wiskott-Aldrich syndrome patients correlate with cell dysfunction
6. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways
7. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization
8. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses
9. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome
10. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation
11. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome
12. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: Collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program
13. Flow cytometric analysis of Wiskott-Aldrich syndrome (WAS) protein in lymphocytes from WAS patients and their familial carriers
14. Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells
15. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome
16. Mutation analysis of five Japanese families with Wiskott-Aldrich syndrome and determination of the family members' carrier status using three different methods
17. Studies of the expression of the Wiskott-Aldrich syndrome protein
18. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center
19. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: Long-term follow-up of 62 cases
20. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation
21. Human memory T cells: Lessons from stem cell transplantation
22. Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott-Aldrich syndrome
23. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism
24. Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: Correlation of accelerated cell death and attenuated bcl-2 expression
25. Actin cyoskeletal function is spared, but apoptosis is inreased, in WAS patient hematopoietic cells